MSB 7.69% $1.19 mesoblast limited

banter and General Discussion, page-7876

  1. 1,896 Posts.
    lightbulb Created with Sketch. 489
    Terrible if realized. Yes. Investing in biotech sucks doesn't it? Except for when it doesn't. You're pretending like it's low risk, high reward.

    You saw that we partnered with BMT, who is funded by the NIH, & thought - "Yup, no sign". Experts in the US are highlighting it's potential and your argument was to immediately looked backwards.

    You said "no sign" literally as there's was a sign. Despite all your other ramblings - you were objectively wrong.
    Last edited by pld89: 23/11/23
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.